PARTICIPATING IN RESEARCH: CLINICAL TRIALS AND REGISTRIES BOBBY - - PowerPoint PPT Presentation

participating in research clinical trials and registries
SMART_READER_LITE
LIVE PREVIEW

PARTICIPATING IN RESEARCH: CLINICAL TRIALS AND REGISTRIES BOBBY - - PowerPoint PPT Presentation

PARTICIPATING IN RESEARCH: CLINICAL TRIALS AND REGISTRIES BOBBY KWANGHOON HAN, MD JENNIFER SCHAEFFER, BS, CCRC SARAH H. CHUNG, MD, MS UNIVERSITY OF WASHINGTON DIVISION OF RHEUMATOLOGY 5/7/2020 TYPES OF RESEARCH IN RHEUMATOLOGY POPULATION


slide-1
SLIDE 1

PARTICIPATING IN RESEARCH: CLINICAL TRIALS AND REGISTRIES

BOBBY KWANGHOON HAN, MD JENNIFER SCHAEFFER, BS, CCRC SARAH H. CHUNG, MD, MS UNIVERSITY OF WASHINGTON DIVISION OF RHEUMATOLOGY 5/7/2020

slide-2
SLIDE 2

TYPES OF RESEARCH IN RHEUMATOLOGY

BASIC SCIENCE CLINICAL POPULATION TRANSLATIONAL QUALITATIVE

Animal studies Disease mechanisms Clinical trials New intervention Epidemiology Large databases Associations/trends Basic Science ↔ Clinical Care Experiential data Patient-reported outcomes Survey data

slide-3
SLIDE 3

WHAT IS TRANSLATIONAL RESEARCH?

  • Studies that take lab

findings to clinical care

  • Studies that take

clinical care to the lab

slide-4
SLIDE 4

WHY IS TRANSLATIONAL RESEARCH IMPORTANT?

  • Using human samples to

study conditions

  • Potential to provide more

tailored clinical care

  • Keeps clinically-pertinent

research questions at the forefront!

slide-5
SLIDE 5

WHAT ARE POPULATION STUDIES?

  • Trends in disease
  • utcomes
  • Factors that affect

disease severity,

  • utcomes, or delivery of

care

  • Environmental or social

exposures that are associated with disease states

slide-6
SLIDE 6

WHY ARE POPULATION STUDIES IMPORTANT?

  • Increases our knowledge
  • f the disease in real-life
  • Allows for understanding
  • f diseases over time
  • Monitor the quality of

care (quality improvement)

slide-7
SLIDE 7

REGISTRIES AND BIOBANKS: WHAT’S THE DIFFERENCE? Registry: Information Biobank: Patient samples (blood, urine, tissue)

slide-8
SLIDE 8

REGISTRIES AND BIOBANKS: WHAT’S THE COMMONALITY? Both allow for storage of information over time

slide-9
SLIDE 9

Registry: Information

  • Patients choose to be part of a

registry and have data collected

  • n:
  • Initial diagnosis features
  • Labs or imaging findings
  • Medications
  • Surgeries or tests performed
  • Lifestyle
  • Family history
slide-10
SLIDE 10

Biobank: Patient samples (blood, urine, tissue)

  • Participants donate

samples.

  • De-identified samples are

kept in secured laboratories in large freezers

  • Accompanied by registry

data

slide-11
SLIDE 11

TYPES OF RESEARCH IN RHEUMATOLOGY

BASIC SCIENCE CLINICAL POPULATION TRANSLATIONAL QUALITATIVE

Animal studies Disease mechanisms Clinical trials New intervention Epidemiology Large databases Associations/trends Basic Science ↔ Clinical Care Experiential data Patient-reported outcomes Survey data

slide-12
SLIDE 12

WHAT IS A CLINICAL TRIAL?

  • A research study that prospectively

evaluates the effects and value of intervention in human participants

  • A source of valuable information

which contributes to advancement

  • f medicine
  • Generate necessary data for

determining whether a new medication is safe and effective by the Food and Drug Administration (FDA)

slide-13
SLIDE 13

CLINICAL TRIAL PHASES

Phase IV Obtain additional information

after approval of the drug

Phase III Assess clinical effectiveness and

adverse effects of the drug

Phase II

Evaluate the effect of the drug in several different doses

Phase I

Estimate tolerability and characterize properties of a drug

slide-14
SLIDE 14

BENEFITS AND RISKS OF CLINICAL TRIALS

Benefits Risks ❖ Play an active role in your own health care ❖ Gain access to new research treatments before they are widely available ❖ Obtain expert medical care at leading health care facilities during the trial ❖ Help others by contributing to medical research ❖ Unpleasant or serious side effects to experimental treatment ❖ Experimental treatment may not be effective for you ❖ Some protocols can be time intensive (trips to the study site, more treatments, hospital stays or complex dosage requirements)

slide-15
SLIDE 15

CLINICAL TRIAL PROCESS

The eligibility of a participant is determined by inclusion and exclusion criteria An informed consent form is reviewed and signed, which describes all the details of clinical trial Participants are asked to visit the clinic according to the protocol and work closely with the research team Participants are closely monitored during the study period and report any new symptoms

slide-16
SLIDE 16

TARGETED ANT NTI-RHEUMATIC THERAPIES

slide-17
SLIDE 17

HOW TO GET INFORMATION ON PARTICIPATING IN RESEARCH

  • clinicaltrials.gov
  • Website of major medical centers
  • rheumatology.uw.edu/research/clinical-trials
  • Arthritis Foundation
slide-18
SLIDE 18

TO LEARN MORE ABOUT THE UW DIVISION OF RHEUMATOLOGY’S COMMITMENT TO RESEARCH, PATIENT CARE AND EDUCATION VISIT OUR WEBSITE AT WWW.RHEUMATOLOGY.UW.EDU THANK YOU!